rs201794569

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_016239.4(MYO15A):​c.1387A>G​(p.Met463Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,612,908 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 3 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 2.94

Publications

10 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011315584).
BP6
Variant 17-18120187-A-G is Benign according to our data. Variant chr17-18120187-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 227634.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.1387A>G p.Met463Val missense_variant Exon 2 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.1387A>G p.Met463Val missense_variant Exon 2 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1
MYO15AENST00000583079.1 linkn.1020A>G non_coding_transcript_exon_variant Exon 1 of 1 6

Frequencies

GnomAD3 genomes
AF:
0.00104
AC:
159
AN:
152220
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00289
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00173
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00127
AC:
315
AN:
248164
AF XY:
0.00144
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.000638
Gnomad ASJ exome
AF:
0.00290
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.0000929
Gnomad NFE exome
AF:
0.00154
Gnomad OTH exome
AF:
0.00182
GnomAD4 exome
AF:
0.00142
AC:
2076
AN:
1460570
Hom.:
3
Cov.:
36
AF XY:
0.00149
AC XY:
1086
AN XY:
726582
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33480
American (AMR)
AF:
0.000514
AC:
23
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00268
AC:
70
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00225
AC:
194
AN:
86258
European-Finnish (FIN)
AF:
0.000153
AC:
8
AN:
52154
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.00152
AC:
1695
AN:
1111978
Other (OTH)
AF:
0.00111
AC:
67
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
142
284
425
567
709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00105
AC:
160
AN:
152338
Hom.:
2
Cov.:
33
AF XY:
0.00101
AC XY:
75
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41584
American (AMR)
AF:
0.000523
AC:
8
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00173
AC:
118
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00138
Hom.:
0
Bravo
AF:
0.000963
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000234
AC:
1
ESP6500EA
AF:
0.00154
AC:
13
ExAC
AF:
0.00125
AC:
151
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00164
EpiControl
AF:
0.00184

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MYO15A: BP4, BS2 -

Feb 10, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27375115, 30953472, 25262649, 22736430, 22903915, 30245029) -

Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not specified Benign:1
Apr 25, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Met463Val in exon 2 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 0.3% (29/10144) Ashkenazi Jewish c hromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstit ute.org; dbSNP rs201794569). In addition, although this variant was previously reported in a family with hearing loss, it was in cis with a pathogenic loss of function variant that was the likely explanation of the hearing loss in that fam ily (Fattahi 2012). -

MYO15A-related disorder Benign:1
Nov 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.015
T;T;T
Eigen
Benign
-0.15
Eigen_PC
Benign
0.057
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.65
T;.;T
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
.;L;L
PhyloP100
2.9
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.3
.;N;.
REVEL
Benign
0.086
Sift
Benign
0.096
.;T;.
Sift4G
Benign
0.091
T;T;.
Polyphen
0.070
.;B;B
Vest4
0.37
MVP
0.33
ClinPred
0.0075
T
GERP RS
5.4
Varity_R
0.17
gMVP
0.64
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201794569; hg19: chr17-18023501; API